https://www.openbell.ai/ 2026-09-16T12:43:34.028Z hourly 1.0 https://www.openbell.ai/support 2026-09-16T12:43:34.028Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-16T12:43:34.028Z monthly 0.5 https://www.openbell.ai/terms 2026-09-16T12:43:34.028Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-16T12:43:34.028Z hourly 0.8 https://www.openbell.ai/news/IRON:1789562500705 2026-09-16T12:41:40.705Z daily 0.9 https://cdn.brandfetch.io/IRON/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Maintains Overweight on Disc Medicine, Raises Price Target to $86 Wells Fargo analyst Derek Archila has maintained an Overweight rating on Disc Medicine (NASDAQ: IRON) and raised the price target from $79 to $86. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/SLVM:1789562373428 2026-09-16T12:39:33.428Z daily 0.9 https://cdn.brandfetch.io/SLVM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wells Fargo Initiates Coverage On Sylvamo with Overweight Rating, Announces Price Target of $47 Wells Fargo analyst Gabe Hajde has initiated coverage on Sylvamo (NYSE: SLVM) with an Overweight rating. The firm has set a price target of $47 for the stock. https://www.openbell.ai/news/JILL:1789562288654 2026-09-16T12:38:08.654Z daily 0.9 https://cdn.brandfetch.io/JILL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Top 3 Consumer Stocks That May Collapse This Month As of September 16, 2026, three consumer discretionary stocks are identified as potentially at risk: MarineMax Inc (NYSE:HZO), J. Jill Inc (NYSE:JILL), and American Outdoor Brands Inc (NASDAQ:AOUT). MarineMax is set to be acquired by Blackrock Infrastructure's Safe Harbor, with its stock up 106% over six months, closing at $52.50. J. Jill reported strong second-quarter results and raised its FY26 sales guidance, with a stock increase of 27% in the past month, closing at $23.63. American Outdoor Brands reported a 25% increase in first-quarter net sales, with its stock rising 26% recently, closing at $15.30. https://www.openbell.ai/news/MYSE:1789562282883 2026-09-16T12:38:02.883Z daily 0.9 https://cdn.brandfetch.io/MYSE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Myseum.AI Partners With FUJIFILM North America To Bring Print-On-Demand Products To Users Of Picture Party Platform Myseum.AI, Inc. has announced a partnership with FUJIFILM North America to introduce print-on-demand products for users of its Picture Party platform. This collaboration aims to enhance revenue opportunities by allowing users to order customizable products such as photo prints, mugs, and canvas prints. The new service is set to launch later this month, leveraging the platform's ability to share high-resolution images without quality degradation. https://www.openbell.ai/news/OSIS:1789562242642 2026-09-16T12:37:22.642Z daily 0.9 https://cdn.brandfetch.io/OSIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud OSI Systems Receives ~$90M Of Orders For Radio Frequency Communication Products From U.S. Government Customers OSI Systems has secured approximately $90 million in orders for radio frequency communication products from U.S. government customers. The products will be used for advanced Very Low Frequency (VLF) communication systems and high frequency transmission products, along with support services. This contract aims to modernize communication infrastructure and enhance performance and reliability. https://www.openbell.ai/news/BURU:1789562216648 2026-09-16T12:36:56.648Z daily 0.9 https://cdn.brandfetch.io/BURU/w/400/h/400?c=1idopYfmtR7ZKg8QMud NUBURU Announces First Pilot Order For Its 1W Laser Dazzler NUBURU, Inc. (NYSE: BURU) has announced its first pilot order for a 1W laser dazzler from a tier-one, government-owned defense integrator in a major Asia-Pacific market. This pilot order could lead to a follow-on program for up to 500 additional units. This engagement follows a previous order of approximately $250,000 for a 7W laser dazzler system, indicating a growing relationship with the customer. https://www.openbell.ai/news/ACGC:1789562143909 2026-09-16T12:35:43.909Z daily 0.9 https://cdn.brandfetch.io/ACGC/w/400/h/400?c=1idopYfmtR7ZKg8QMud May Mobility To Go Public Via $1.4B Business Combination With ACP Holdings Acquisition Corp.; Listing On Nasdaq Under Ticker "MAY" May Mobility, Inc. has announced a definitive business combination agreement with ACP Holdings Acquisition Corp., which will allow May Mobility to go public with an implied enterprise value of approximately $1.4 billion. The transaction is expected to generate gross proceeds of up to $337 million, depending on shareholder redemptions. Following the completion of the deal, May Mobility will be listed on the Nasdaq under the ticker symbol 'MAY'. https://www.openbell.ai/news/DLHC:1789562131779 2026-09-16T12:35:31.779Z daily 0.9 https://cdn.brandfetch.io/DLHC/w/400/h/400?c=1idopYfmtR7ZKg8QMud DLH Holdings Announces Up To $43.7M Task Order To Continue IT Services For National Heart, Lung, And Blood Institute Over 2.5 Years openbell Financial News https://www.openbell.ai/news/FGNX:1789562128090 2026-09-16T12:35:28.090Z daily 0.9 https://cdn.brandfetch.io/FGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud FG Nexus Board Approves Strategy To Acquire Affordable Housing Communities And Make $10M Investment In FG Communities; Company Plans To Change Its Name To FG Communities Holdings FG Nexus (NASDAQ: FGNX) has received Board approval to acquire affordable housing communities and invest $10 million in FG Communities, representing about 10% of its outstanding stock. The company plans to transition into a real estate operating company focused on land-lease affordable housing, with a strategy involving direct property acquisitions funded through cash, debt, and stock issuances. Additionally, FG Nexus intends to change its name to FG Communities Holdings, Inc. and its ticker symbols to FGC and FGCPP, respectively, pending regulatory approval. https://www.openbell.ai/news/CRML:1789562122105 2026-09-16T12:35:22.105Z daily 0.9 https://cdn.brandfetch.io/CRML/w/400/h/400?c=1idopYfmtR7ZKg8QMud Critical Metals Announces Tanbreez Project And Romania Refinery Forecasts; Sees Annual Revenue Of ~$2.2B Before Operating Costs, Taxes And Capital Recovery; Modelling Indicates An NPV10 Of ~$4.5B With IRR Of ~55% And Projected Payback Period Of ~2 Years Critical Metals (CRML) announced its Tanbreez Project and Romania refinery forecasts, projecting annual revenue of approximately $2.2 billion before operating costs, taxes, and capital recovery. The refinery, designed to process up to 100,000 tons of eudialyte concentrate per year, is expected to generate an NPV10 of around $4.5 billion with an internal rate of return (IRR) of about 55% and a payback period of approximately two years. The refinery will utilize innovative processes to enhance project economics and aims to produce high-purity rare earth and critical metal products, including significant by-products like SiO2, potentially contributing an additional $600 million in revenue annually. https://www.openbell.ai/news/CUPR:1789562005956 2026-09-16T12:33:25.956Z daily 0.9 https://cdn.brandfetch.io/CUPR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cuprina Holdings Announces Pricing Of $4.97M Public Offering Of 4,322,489 Class A Ordinary Shares At $1.15/Share; Expects Close On Or About September 17 openbell Financial News https://www.openbell.ai/news/BAK:1789561924912 2026-09-16T12:32:04.912Z daily 0.9 https://cdn.brandfetch.io/BAK/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Downgrades Braskem to Sell, Lowers Price Target to $1.5 UBS analyst Tasso Vasconcellos has downgraded Braskem (NYSE: BAK) from Neutral to Sell, reducing the price target from $4 to $1.5. This change reflects a negative outlook on the company's performance. https://www.openbell.ai/news/SBFM:1789561865035 2026-09-16T12:31:05.035Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Close-up-Of-Coronavirus-Bacteria-Plastic.jpg?width=250&height=187 EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies Sunshine Biopharma Inc. (NASDAQ: SBFM) has advanced its lead Coronavirus drug candidate into IND-enabling studies, demonstrating nanomolar potency against the viral protease and broad-spectrum activity against SARS-CoV-2 variants in vitro. The drug candidate showed high oral bioavailability and preferential lung enrichment in animal studies, significantly suppressing pulmonary viral replication in a dose-dependent manner. Despite this progress, Sunshine Biopharma's shares fell 0.97% to $1.02 during premarket trading, nearing its 52-week low of $1.01. https://www.openbell.ai/news/COIN:1789561856708 2026-09-16T12:30:56.708Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $COIN Bullish sentiment on COIN ahead of the Senate vote on the CLARITY Act, with discussions of a potential gamma squeeze. However, there are warnings of possible losses for those betting against it. https://www.openbell.ai/news/SPY:1789561853427 2026-09-16T12:30:53.427Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Core Retail Sales (MoM) For August 1.4% Vs 0.6% Est. openbell Financial News https://www.openbell.ai/news/SBFM:1789561826209 2026-09-16T12:30:26.209Z daily 0.9 https://cdn.brandfetch.io/SBFM/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study openbell Financial News https://www.openbell.ai/news/XRPUSD:1789561826136 2026-09-16T12:30:26.136Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Kyrenia--Cyprus---November-8--2018-Rippl.jpg?width=250&height=187 Ripple CEO Blames Democrats' 'Politics' for CLARITY Act Failure Ripple CEO Brad Garlinghouse criticized Senate Democrats for the failure of the CLARITY Act, which he believes has left consumers and U.S. competitiveness behind. Despite this setback, Garlinghouse noted that Ripple and XRP remain largely unscathed and expressed optimism for future crypto regulation through rulemaking by the SEC and CFTC. XRP's price recently fell below key support levels, but institutional demand has remained strong, with no outflows recorded from U.S. spot XRP ETFs. https://www.openbell.ai/news/SPY:1789561819010 2026-09-16T12:30:19.010Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Retail Sales (MoM) For August 1.2% Vs 0.8% Est. openbell Financial News https://www.openbell.ai/news/SPY:1789561818643 2026-09-16T12:30:18.643Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Retail Sales Ex Gas/Autos (MoM) For August 1.2% Vs -0.3% Prior openbell Financial News https://www.openbell.ai/news/SPY:1789561813250 2026-09-16T12:30:13.250Z daily 0.9 https://cdn.brandfetch.io/SPY/w/400/h/400?c=1idopYfmtR7ZKg8QMud USA Retail Control (MoM) For August 1.4% Vs 0.4% Est.; 0.4% Prior openbell Financial News https://www.openbell.ai/news/UNP:1789561736427 2026-09-16T12:28:56.427Z daily 0.9 https://cdn.brandfetch.io/UNP/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Upgrades Union Pacific to Buy, Raises Price Target to $339 UBS analyst Thomas Wadewitz has upgraded Union Pacific (NYSE: UNP) from Neutral to Buy. The price target for the stock has been raised from $310 to $339. https://www.openbell.ai/news/MRVL:1789561692610 2026-09-16T12:28:12.610Z daily 0.9 https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud What's Going On With Marvell Technology Stock Wednesday? Marvell Technology, Inc. (NASDAQ: MRVL) stock rose by over 2% in premarket trading, reaching $226.50, as semiconductor stocks gained momentum. Bank of America analyst Vivek Arya highlighted that Marvell may be underestimating its AI market potential, estimating it could capture about $30 billion of a $60 billion to $65 billion market by 2030. The stock has a Buy consensus rating with an average price forecast of $295.25, while it trades at a price-to-earnings ratio of approximately 73.4. https://www.openbell.ai/news/MRVL:1789561673863 2026-09-16T12:27:53.863Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Kanata--Ottawa--On--Canada---October-15-.jpg?width=250&height=187 What's Going On With Marvell Technology Stock Wednesday? Marvell Technology, Inc. (NASDAQ: MRVL) stock rose by over 2% during Wednesday's premarket session, trading at $226.50. Bank of America analyst Vivek Arya highlighted that Marvell may be underestimating its AI market potential, estimating a $300 billion market for custom AI chips by 2030, with Marvell potentially capturing $30 billion of the XPU attach market. The stock maintains a Buy consensus rating with an average price forecast of $295.25, while trading at a price-to-earnings ratio of approximately 73.4. https://www.openbell.ai/news/BB:1789561646714 2026-09-16T12:27:26.714Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/BlackBerry-Limited.jpg?width=250&height=187 BlackBerry Beat Last Quarter's EPS Estimate by 33% — Can It Repeat That Sept. 24? BlackBerry Limited (NYSE: BB) is set to report its second-quarter fiscal 2027 earnings on September 24, with analysts expecting an EPS of 4 cents and revenue of $145.63 million. In the previous quarter, the company reported an EPS of 4 cents and revenue of $152.9 million, both exceeding estimates. The QNX segment saw a 26% year-over-year growth to $72.3 million, driven by increased development licenses. Currently, BlackBerry shares are trading at $7.89, reflecting a 1.15% increase. https://www.openbell.ai/news/OPTH:1789561631496 2026-09-16T12:27:11.496Z daily 0.9 https://cdn.brandfetch.io/OPTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Optimi Health Plans To Initiate A Phase 3 Clinical Trial Evaluating MDMA-Assisted Therapy For PTSD Authorized By Health Canada; Trial Is Expected To Begin In 2027 Optimi Health plans to initiate a Phase 3 clinical trial for MDMA-assisted therapy targeting PTSD, authorized by Health Canada, with the trial expected to begin in 2027. The trial aims to enroll up to 100 participants, focusing on veterans and frontline workers, and will assess the therapy's efficacy using the Clinician-Administered PTSD Scale (CAPS-5). This follows the company's Phase 2 trial of natural psilocybin for major depressive disorder. Currently, none of Optimi's MDMA products have received market authorization from Health Canada. https://www.openbell.ai/news/NUVB:1789561430769 2026-09-16T12:23:50.769Z daily 0.9 https://cdn.brandfetch.io/NUVB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price Target Wedbush analyst David Nierengarten has reiterated an 'Outperform' rating on Nuvation Bio (NYSE: NUVB) and has maintained a price target of $11 for the stock. https://www.openbell.ai/news/COGT:1789561354471 2026-09-16T12:22:34.471Z daily 0.9 https://cdn.brandfetch.io/COGT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Cogent Biosciences, Maintains $55 Price Target Wedbush analyst David Nierengarten has reiterated an 'Outperform' rating on Cogent Biosciences (NASDAQ: COGT) and maintained a price target of $55 for the stock. No additional financial figures or strategic changes were mentioned in the article. https://www.openbell.ai/news/RCKT:1789561258941 2026-09-16T12:20:58.941Z daily 0.9 https://cdn.brandfetch.io/RCKT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wedbush Reiterates Outperform on Rocket Pharmaceuticals, Maintains $15 Price Target Wedbush analyst Yun Zhong has reiterated an Outperform rating on Rocket Pharmaceuticals (NASDAQ: RCKT) and maintained a price target of $15 for the stock. This endorsement suggests confidence in the company's future performance. https://www.openbell.ai/news/RKLB:1789561217489 2026-09-16T12:20:17.489Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Rocket-Lab-Beats-Q3-Revenue-Expectations.jpg?width=250&height=187 Rocket Lab Fully Finances Its Iridium Deal — Here's What Else Happened This Week Rocket Lab Corporation (NASDAQ: RKLB) successfully launched its 16th Electron mission of the year on September 11, deploying an Earth observation satellite. The company also announced it has fully financed its pending acquisition of Iridium Communications, raising approximately $1.944 billion through an At-The-Market share offering. Additionally, Iridium amended its $1.775 billion term loan facility, and Rocket Lab terminated a $3.6 billion senior secured bridge facility related to the acquisition, which is expected to close in mid-2027 pending regulatory approvals. As of the latest update, Rocket Lab shares are trading at $63.76, up 0.33%. https://www.openbell.ai/news/KO:1789561152712 2026-09-16T12:19:12.712Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Minsk--Belarus--July-13--2023---Electron.jpg?width=250&height=187 Coca-Cola Plans $10 Billion US Investment Through 2030 — Here's Where the Beverage Giant Will Build Out its Network Coca-Cola Co. plans to invest $10 billion in U.S. infrastructure from 2026 through 2030 to expand its production and distribution network across several states, including California and New York. This investment will primarily be funded by its bottling partners, as Coca-Cola operates an asset-light model. The announcement follows a strong second-quarter performance, with revenue of $13.4 billion, a 7% year-over-year increase, and an adjusted earnings per share of 97 cents. Coca-Cola shares closed at $88.71, down 0.12% on the day of the announcement. https://www.openbell.ai/news/MAIA:1789561006852 2026-09-16T12:16:46.852Z daily 0.9 https://cdn.brandfetch.io/MAIA/w/400/h/400?c=1idopYfmtR7ZKg8QMud MAIA Biotechnology Says First US Patient Dosed In Phase 2 THIO-101 Trial Expansion Evaluating Telomere-Targeting Lead Candidate, Ateganosine, In Third-Line Non-Small Cell Lung Cancer MAIA Biotechnology has announced the dosing of the first U.S. patient in its Phase 2 THIO-101 trial expansion for ateganosine, a treatment for third-line non-small cell lung cancer (NSCLC). This trial expansion is supported by a $2.3 million grant from the National Institutes of Health (NIH) and involves the activation of three sites in the U.S. MAIA has received FDA Fast Track designation for ateganosine, which has shown promising overall survival results in previous trial phases. https://www.openbell.ai/news/EAT:1789560857941 2026-09-16T12:14:17.941Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Stuttgart--Germany---07-05-2024-Person-H.jpg?width=250&height=187 This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Seaport Global analyst Eric Gonzalez initiated coverage on Brinker International Inc (NYSE:EAT) with a Buy rating and set a price target of $230, while the stock closed at $203.47 on Tuesday. This marks a positive outlook for the company as analysts begin to assess its market potential. The article also highlights other companies receiving analyst coverage, including McDonald's and Corvex Inc. https://www.openbell.ai/news/NVO:1789560834129 2026-09-16T12:13:54.129Z daily 0.9 https://cdn.brandfetch.io/NVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Novo Nordisk Announces Collaboration With Anthropic To Use Claude Science And Anthropic Models For Drug Discovery, Software Development Novo Nordisk has announced a collaboration with Anthropic to leverage Claude Science and Anthropic models for drug discovery and software development. This partnership aims to enhance the efficiency and effectiveness of Novo Nordisk's research and development processes. The collaboration reflects Novo Nordisk's commitment to integrating advanced AI technologies into its operations. https://www.openbell.ai/news/TCOM:1789560817058 2026-09-16T12:13:37.058Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Stuttgart--Germany---12-30-2022-Mobile-P.jpg?width=250&height=187 More Than 70% of Trip.com Bookings Now Come From Mobile Trip.com Group reported a 6% year-over-year increase in net revenue to 15.7 billion Chinese yuan for the second quarter, surpassing analyst estimates. Adjusted earnings per share rose to 7.27 Chinese yuan, or $1.07, exceeding the expected $0.91. More than 70% of bookings now come from mobile, reflecting a shift towards a smoother booking experience. The company also plans to attract 200 million inbound travelers over the next five years and is implementing changes to its distribution programs and data security measures. https://www.openbell.ai/news/TRAX:1789560725303 2026-09-16T12:12:05.303Z daily 0.9 https://cdn.brandfetch.io/TRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100 Guggenheim analyst Yatin Suneja has initiated coverage on First Tracks (NASDAQ: TRAX) with a Buy rating. The firm has set a price target of $100 for the stock. https://www.openbell.ai/news/TOPS:1789560700560 2026-09-16T12:11:40.560Z daily 0.9 https://cdn.brandfetch.io/TOPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud TOP Ships H1 EPS $0.61 Down From $1.63 YoY, Sales $25.475M Down From $43.811M YoY TOP Ships (NASDAQ: TOPS) reported a first-half earnings per share (EPS) of $0.61, a decline of 62.58% from $1.63 in the same period last year. The company's sales totaled $25.475 million, down 41.85% from $43.811 million year-over-year. https://www.openbell.ai/news/KBH:1789560685611 2026-09-16T12:11:25.611Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/16/Dec-8--2019-Los-Angeles--Ca--Usa.jpg?width=250&height=187 How To Earn $500 A Month From KB Home Stock Ahead Of Q3 Earnings KB Home (NYSE: KBH) is set to release its Q3 earnings on September 22, with analysts expecting earnings of 90 cents per share, a decline from $1.61 in the previous year, and quarterly revenue of $1.30 billion, down from $1.62 billion last year. Wells Fargo analyst Sam Reid has maintained an Underweight rating on the stock, lowering the price target from $52 to $50. Currently, KB Home offers a quarterly dividend of 25 cents per share, translating to an annual yield of 2.02%, requiring an investment of approximately $297,120 to generate a monthly income of $500 from dividends. As of the latest trading session, KB Home shares closed at $49.52, reflecting a slight decrease of 0.1%. https://www.openbell.ai/news/FTH:1789560646899 2026-09-16T12:10:46.899Z daily 0.9 https://cdn.brandfetch.io/FTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Initiates Coverage On Faeth Therapeutics with Buy Rating, Announces Price Target of $70 Guggenheim analyst Brad Canino has initiated coverage on Faeth Therapeutics (NASDAQ: FTH) with a Buy rating. The firm has set a price target of $70 for the stock. https://www.openbell.ai/news/SLDB:1789560556638 2026-09-16T12:09:16.638Z daily 0.9 https://cdn.brandfetch.io/SLDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Initiates Coverage On Solid Biosciences with Outperform Rating, Announces Price Target of $18 RBC Capital analyst Luca Issi has initiated coverage on Solid Biosciences (NASDAQ: SLDB) with an Outperform rating. The firm has set a price target of $18 for the stock. https://www.openbell.ai/news/TNMG:1789560550100 2026-09-16T12:09:10.100Z daily 0.9 https://cdn.brandfetch.io/TNMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud TNL Mediagene Reports Cumulative GMV Of ¥1.1B+ From Three Co-Development Campaigns Between Its Unit Gizmart And Keychron TNL Mediagene reported a cumulative Gross Merchandise Value (GMV) of over ¥1.1 billion from three co-development campaigns with Keychron, including the Keychron Nape Pro and Keychron Orca echo. The Keychron Orca echo campaign generated ¥704.6 million in GMV, while the two Keychron Nape Pro campaigns contributed approximately ¥420.4 million. The partnership is set to continue with preparations for their next co-development project, and the commerce platform CoSTORY has seen a 4.4x year-over-year increase in registered membership, reaching around 87,000 members as of August 2026. https://www.openbell.ai/news/VIVS:1789560417402 2026-09-16T12:06:57.402Z daily 0.9 https://cdn.brandfetch.io/VIVS/w/400/h/400?c=1idopYfmtR7ZKg8QMud VivoSim Labs Says New Data At EUROTOX 2026 Show Its 3D Human Liver And Intestine Models Predicted Drug Toxicity For Small Molecules And Antibody-Drug Conjugates openbell Financial News https://www.openbell.ai/news/MEDS:1789560363040 2026-09-16T12:06:03.040Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Health Care Stocks Moving In Wednesday's Pre-Market Session In Wednesday's pre-market session, DataMEDS AI (NASDAQ: MEDS) saw a significant increase of 124.1%, reaching a price of $3.63, with a market cap of $4.9 million. Other notable gainers included Tempest Therapeutics (NASDAQ: TPST), which rose by 40.21% to $1.06, and Senti Biosciences (NASDAQ: SNTI), which increased by 16.66% to $0.35. Conversely, Cuprina Holdings (Cayman) (NASDAQ: CUPR) experienced the largest decline, falling 34.8% to $1.91, while Xenetic Biosciences (NASDAQ: XBIO) dropped 33.49% to $2.84. https://www.openbell.ai/news/ZTG:1789560362791 2026-09-16T12:06:02.791Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Wednesday's Pre-Market Session In Wednesday's pre-market session, Zenta Group Co (NASDAQ: ZTG) shares surged 311.5% to $2.77, with a market cap of $7.9 million. YYForce (NASDAQ: YFOR) and Einride (NASDAQ: ENRD) also saw significant gains, rising 21.42% to $1.7 and 15.73% to $4.34, respectively. Conversely, First Breach (NASDAQ: FBDT) experienced the largest decline, falling 26.1% to $0.74, while JB Hunt Transport Services (NASDAQ: JBHT) decreased by 10.64% to $244.0. https://www.openbell.ai/news/ARBB:1789560362501 2026-09-16T12:06:02.501Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session In Wednesday's pre-market session, ARB IOT Group (NASDAQ: ARBB) saw its stock rise by 13.3% to $4.79, with a market cap of $7.4 million. Other notable gainers included Locafy (NASDAQ: LCFY), up 10.61% to $2.5, and Nokia (NYSE: NOK), which increased by 5.89% to $10.42, with a market value of $54.9 billion. Conversely, Advasa Holdings (NASDAQ: ADBT) experienced the largest decline, falling 20.4% to $0.1, while My Size (NASDAQ: MYSZ) dropped 18.54% to $1.89. https://www.openbell.ai/news/MRCY:1789560336825 2026-09-16T12:05:36.825Z daily 0.9 https://cdn.brandfetch.io/MRCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mercury Systems Reaffirms FY27 Guidance And Extends Employment Contract Of Chairman And CEO Bill Ballhaus Through August 15, 2030 Mercury Systems reaffirmed its FY27 guidance during the Q4 conference call on August 18, projecting organic growth in the low double digits, an adjusted EBITDA margin in the high teens, and free cash flow conversion nearing 35%. Additionally, the company extended the employment contract of Chairman and CEO Bill Ballhaus through August 15, 2030. https://www.openbell.ai/news/ALZN:1789560297360 2026-09-16T12:04:57.360Z daily 0.9 https://cdn.brandfetch.io/ALZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alzamend Neuro Regains Nasdaq Compliance Alzamend Neuro, Inc. has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving a notification letter from Nasdaq on September 14, 2026. The company demonstrated stockholders' equity of $5,802,680, exceeding the required minimum of $2.5 million, as reported in its Quarterly Report for the quarter ended July 31, 2026. Nasdaq confirmed that the compliance issue is now resolved. https://www.openbell.ai/news/CRWV:1789560278089 2026-09-16T12:04:38.089Z daily 0.9 https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud CoreWeave Announces Bring Up Of Multi-Rack NVIDIA Vera Rubin NVL72 Clusters On CoreWeave Cloud openbell Financial News https://www.openbell.ai/news/TWST:1789560261756 2026-09-16T12:04:21.756Z daily 0.9 https://cdn.brandfetch.io/TWST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Twist Bioscience Announces Agreement With Lilly TuneLab To Advance Antibody Drug Discovery openbell Financial News https://www.openbell.ai/news/MOVE:1789560247736 2026-09-16T12:04:07.736Z daily 0.9 https://cdn.brandfetch.io/MOVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Chardan Capital Initiates Coverage On Corvex with Buy Rating, Announces Price Target of $18.75 Chardan Capital has initiated coverage on Corvex (NASDAQ: MOVE) with a Buy rating. Analyst Bill Papanastasiou has set a price target of $18.75 for the stock. https://www.openbell.ai/news/LYFT:1789560243608 2026-09-16T12:04:03.608Z daily 0.9 https://cdn.brandfetch.io/LYFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sphere Entertainment And Lyft Announce Multi-Year Marketing Partnership Naming Lyft Official Rideshare Partner Of Sphere openbell Financial News